Doxorubicin Modulated Clock Genes and Cytokines in Macrophages Extracted from Tumor-bearing Mice
Overview
Pharmacology
Authors
Affiliations
Methods: Macrophages were extracted from intraperitoneal cavity of mice without or with Lewis lung carcinoma (LLC) and treated with DOX totaling four groups (CTL, LLC, LLC+DOX and DOX) and analyzes of clock genes in six time points (ZT02, ZT06, ZT10, ZT14, ZT18 AND ZT22). Intraperitoneal macrophages cell culture was stimulated with LPS and DOX and clock genes and inflammatory profile were analyzed. In tumor were analyzed macrophages markers.
Results: The expression of F4/80 (ZT22) and CD11c (ZT06) tumor tissue was significantly differed between LLC and LCC+DOX groups. In the intraperitoneal macrophages, DOX increased Clock (ZT10), Rev-Erbα (ZT18 and ZT22) and Per2 expressions (ZT18); in the LLC+DOX group was increased Bmal1 (ZT10), Per2 (ZT18) and NF-kB (ZT22) expressions; IL-6 expression increased in the LCC group (ZT02). In intraperitoneal macrophages cell culture stimulated with DOX and LPS after 24 h decreased Clock and Per1. DOX causes depression after 6 and 24 h in TNF-α content and Per2 gene expression after 24 h IL-1β expression was reduced also.
Conclusion: DOX treatment in vivo disrupted cytokine and clock genes expression in intraperitoneal macrophages suppressing immune response. Moreover, macrophages cultured with DOX had decreased expression of LPS-stimulated inflammatory cytokines.
Shao F, Wang Z, Ye L, Wu R, Wang J, Yu Q Burns Trauma. 2025; 13():tkae075.
PMID: 39830193 PMC: 11741524. DOI: 10.1093/burnst/tkae075.
Tian Y, Luan X, Yang K Heliyon. 2024; 10(10):e30708.
PMID: 38803898 PMC: 11128472. DOI: 10.1016/j.heliyon.2024.e30708.
Ding L, Duan J, Yang T, Jin C, Lv S, Ma A Front Physiol. 2024; 15:1301450.
PMID: 38742154 PMC: 11089382. DOI: 10.3389/fphys.2024.1301450.
Major roles of the circadian clock in cancer.
Huang C, Zhang C, Cao Y, Li J, Bi F Cancer Biol Med. 2023; 20(1).
PMID: 36647780 PMC: 9843445. DOI: 10.20892/j.issn.2095-3941.2022.0474.
Mirian M, Hariri A, Yadollahi M, Kohandel M Cancers (Basel). 2022; 14(6).
PMID: 35326729 PMC: 8945968. DOI: 10.3390/cancers14061578.